Mechanisms of the Development of Cardiotoxicity in Breast Cancer Chemirterapy

dc.contributor.author	Juraeva N.O
dc.contributor.author	Makhmanazarov O.M
dc.contributor.author	Hamroev R.R
dc.date.accessioned	2026-01-01T21:15:53Z
dc.date.issued	2023-02-26
dc.description.abstract	Modern treatment of breast cancer is associated with risks of cardiotoxicity. The article presents the mechanisms of cardiotoxicity development on the example of drugs used in the treatment of breast cancer (anthracyclines and a targeted drug - trastuzumab). Diagnostic methods, their advantages and disadvantages, the algorithm of diagnosis and continuation of therapy of patients receiving cardiotoxic therapy of breast cancer are presented.
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/erb/article/view/3499
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/67023
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/erb/article/view/3499/2962
dc.source	Eurasian Research Bulletin ; Vol. 17 (2023): ERB; 280-284
dc.source	2795-7675
dc.subject	chemotherapy
dc.subject	targeted therapy
dc.subject	cardiomyopathy
dc.title	Mechanisms of the Development of Cardiotoxicity in Breast Cancer Chemirterapy
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: no_2023_mechanisms_of_the_development_of_cardiot.pdf
item.page.filesection.size: 200.41 KB
item.page.filesection.format: Adobe Portable Document Format